PMV Pharmaceuticals, Inc. (PMVP)

NASDAQ: PMVP · Real-Time Price · USD

1.220

-0.020 (-1.61%)

At close: Aug 28, 2026, 4:00 PM EDT

1.225

+0.005 (0.41%)

After-hours: Aug 28, 2026, 7:30 PM EDT

PMV Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.47	37.98	40.88	37.71	108.3	172.47
Short-Term Investments	66.96	74.96	128.58	165.35	132.76	124.7
Cash & Short-Term Investments	79.43	112.94	169.45	203.06	241.05	297.16
Cash Growth	-44.17%	-33.35%	-16.55%	-15.76%	-18.88%	-17.78%
Prepaid Expenses	1.98	2.28	6.2	3.53	5.13	3.3
Restricted Cash	-	-	-	0.82	0.82	0.82
Total Current Assets	81.41	115.23	175.66	207.41	247.01	301.29
Property, Plant & Equipment	0.36	1.04	1.55	19.05	20.49	13.15
Long-Term Investments	-	-	13.84	25.51	2.5	16.91
Other Long-Term Assets	0.3	0.3	0.24	0.19	0.31	0.22
Total Assets	82.07	116.56	191.29	252.15	270.31	331.57

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	2.02	3.16	6.58	3.24	3	3.19
Accrued Expenses	8.33	7.86	7.44	9.94	7.31	8.63
Current Portion of Leases	0.22	0.4	0.35	0.85	0.53	0.4
Total Current Liabilities	10.57	11.42	14.37	14.03	10.83	12.22
Long-Term Leases	-	0.44	0.84	12.43	13.45	10.79
Total Liabilities	10.57	11.85	15.21	26.46	24.28	23.01

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Additional Paid-In Capital	554.16	551.08	544.65	535.47	487.52	476.36
Retained Earnings	-482.58	-446.45	-368.71	-310	-241.04	-167.73
Comprehensive Income & Other	-0.08	0.08	0.14	0.22	-0.45	-0.08
Total Common Equity	71.5	104.71	176.08	225.69	246.03	308.56
Shareholders' Equity	71.5	104.71	176.08	225.69	246.03	308.56
Total Liabilities & Equity	82.07	116.56	191.29	252.15	270.31	331.57

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.22	0.84	1.19	13.29	13.98	11.19
Net Cash (Debt)	79.21	112.11	182.11	215.28	229.57	302.88
Net Cash Growth	-46.22%	-38.44%	-15.41%	-6.23%	-24.20%	-16.20%
Net Cash Per Share	1.49	2.13	3.53	4.48	5.04	6.71
Filing Date Shares Outstanding	53.46	53.33	51.93	51.44	45.77	45.45
Total Common Shares Outstanding	53.46	53.33	51.94	51.45	45.77	45.43
Working Capital	70.84	103.81	161.29	193.38	236.17	289.07
Book Value Per Share	1.34	1.96	3.39	4.39	5.38	6.79
Tangible Book Value	71.5	104.71	176.08	225.69	246.03	308.56
Tangible Book Value Per Share	1.34	1.96	3.39	4.39	5.38	6.79
Machinery	1.46	1.48	1.82	3.17	2.53	2.28
Leasehold Improvements	0.05	0.08	0.05	10.77	0.41	0.16

SEC Filings: 10-K · 10-Q